Vaneck Vectors Global Health Leaders ETF (ASX:HLTH)
11.81
-0.03 (-0.25%)
At close: Feb 26, 2026
ASX:HLTH Holdings Information
ASX:HLTH is an equity ETF with a total of 10 individual holdings. The top holdings are Globus Medical stock at 3.00%, Swedish Orphan Biovitrum AB at 2.78%, Chugai Pharmaceutical at 2.65%, Merck & Co. at 2.63%, and Regeneron Pharmaceuticals at 2.51%.
Total Holdings
10
Top 10 Percentage
25.88%
Asset Class
Equity
ETF Category
Health Care
Assets
52.03M
PE Ratio
17.86
Breakdown by Sector
Top 25 Holdings
| No. | Symbol | Name | % Weight |
|---|---|---|---|
| 1 | GMED | Globus Medical, Inc. | 3.00% |
| 2 | STO: SOBI | Swedish Orphan Biovitrum AB (publ) | 2.78% |
| 3 | TYO: 4519 | Chugai Pharmaceutical Co., Ltd. | 2.65% |
| 4 | MRK | Merck & Co., Inc. | 2.63% |
| 5 | REGN | Regeneron Pharmaceuticals, Inc. | 2.51% |
| 6 | AMGN | Amgen Inc. | 2.50% |
| 7 | JNJ | Johnson & Johnson | 2.49% |
| 8 | LLY | Eli Lilly and Company | 2.46% |
| 9 | ILMN | Illumina, Inc. | 2.44% |
| 10 | BMY | Bristol-Myers Squibb Company | 2.41% |
As of Feb 26, 2026